Literature DB >> 34519177

HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non-hospital settings in the community.

Binyamin Ben Avraham1, Marisa Generosa Crespo-Leiro2, Gerasimos Filippatos3,4, Israel Gotsman5, Petar Seferovic6, Tal Hasin7, Luciano Potena8, Davor Milicic9, Andrew J S Coats10, Giuseppe Rosano11, Frank Ruschitzka12, Marco Metra13, Stefan Anker14, Johann Altenberger15, Stamatis Adamopoulos16, Yaron D Barac17, Ovidiu Chioncel18, Nicolaas De Jonge19, Jeremy Elliston20, Maria Frigeiro21, Eva Goncalvesova22, Avishay Grupper23,24, Righab Hamdan25, Yoav Hammer1, Loreena Hill26, Osnat Itzhaki Ben Zadok1, Miriam Abuhazira17, Jacob Lavee24,27, Wilfried Mullens28, Sanemn Nalbantgil29, Massimo F Piepoli30, Piotr Ponikowski31, Arsen Ristic32, Arjang Ruhparwar33, Aviv Shaul1, Laurens F Tops34, Steven Tsui35, Stephan Winnik36,37, Tiny Jaarsma38, Finn Gustafsson39, Tuvia Ben Gal1.   

Abstract

The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of the LVAD-supported patients on the device and the scarcity of donor hearts has significantly increased the population of LVAD-supported patients. The expected and non-expected device-related and patient-device interaction complications impose a significant burden on the medical system exceeding the capacity of the LVAD implanting centres. The ageing of the LVAD-supported patients, mainly those supported with the 'destination therapy' indication, increases the risk for those patients to experience comorbidities common in the older population. The probability of an LVAD-supported patient presenting with medical emergency to a local emergency department, internal, or surgical ward of a non-LVAD implanting centre is increasing. The purpose of this trilogy is to supply the immediate tools needed by the non-LVAD specialized physician: ambulance clinicians, emergency ward physicians, general cardiologists, internists, anaesthesiologists, and surgeons, to comply with the medical needs of this fast-growing population of LVAD-supported patients. The different issues discussed will follow the patient's pathway from the ambulance to the emergency department and from the emergency department to the internal or surgical wards and eventually to the discharge home from the hospital back to the general practitioner. In this first part of the trilogy on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider, after the introduction on the assist devices technology in general, definitions and structured approach to the assessment of the LVAD-supported patient in the ambulance and emergency department is presented including cardiopulmonary resuscitation for LVAD-supported patients.
© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Entities:  

Keywords:  CPR; Emergency medical systems; General description; LVAD

Mesh:

Year:  2021        PMID: 34519177      PMCID: PMC8712781          DOI: 10.1002/ehf2.13588

Source DB:  PubMed          Journal:  ESC Heart Fail        ISSN: 2055-5822


  39 in total

1.  Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device.

Authors:  Mathias C Busch; Michael Haap; Arnt Kristen; Christian S Haas
Journal:  Ann Emerg Med       Date:  2010-07-31       Impact factor: 5.721

2.  A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.

Authors:  Mandeep R Mehra; Nir Uriel; Yoshifumi Naka; Joseph C Cleveland; Melana Yuzefpolskaya; Christopher T Salerno; Mary N Walsh; Carmelo A Milano; Chetan B Patel; Steven W Hutchins; John Ransom; Gregory A Ewald; Akinobu Itoh; Nirav Y Raval; Scott C Silvestry; Rebecca Cogswell; Ranjit John; Arvind Bhimaraj; Brian A Bruckner; Brian D Lowes; John Y Um; Valluvan Jeevanandam; Gabriel Sayer; Abeel A Mangi; Ezequiel J Molina; Farooq Sheikh; Keith Aaronson; Francis D Pagani; William G Cotts; Antone J Tatooles; Ashok Babu; Don Chomsky; Jason N Katz; Paul B Tessmann; David Dean; Arun Krishnamoorthy; Joyce Chuang; Ia Topuria; Poornima Sood; Daniel J Goldstein
Journal:  N Engl J Med       Date:  2019-03-17       Impact factor: 91.245

3.  Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study).

Authors:  Daniel J Cantillon; Walid I Saliba; Oussama M Wazni; Mohamed Kanj; Randall C Starling; W H Wilson Tang; Bruce L Wilkoff
Journal:  J Heart Lung Transplant       Date:  2013-11-28       Impact factor: 10.247

4.  Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques.

Authors:  T Jared Bunch; Andy Darby; Heidi T May; Michael Ragosta; D Scott Lim; Angela M Taylor; John P DiMarco; Gorav Ailawadi; James R Revenaugh; J Peter Weiss; Srijoy Mahapatra
Journal:  Europace       Date:  2011-11-11       Impact factor: 5.214

5.  In-hospital cardiopulmonary arrests in patients with left ventricular assist devices.

Authors:  Sonia Garg; Colby R Ayers; Catherine Fitzsimmons; Dan Meyer; Matthias Peltz; Brian Bethea; William Cornwell; Faris Araj; Jennifer Thibodeau; Mark H Drazner
Journal:  J Card Fail       Date:  2014-12       Impact factor: 5.712

6.  HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non-hospital settings in the community.

Authors:  Binyamin Ben Avraham; Marisa Generosa Crespo-Leiro; Gerasimos Filippatos; Israel Gotsman; Petar Seferovic; Tal Hasin; Luciano Potena; Davor Milicic; Andrew J S Coats; Giuseppe Rosano; Frank Ruschitzka; Marco Metra; Stefan Anker; Johann Altenberger; Stamatis Adamopoulos; Yaron D Barac; Ovidiu Chioncel; Nicolaas De Jonge; Jeremy Elliston; Maria Frigeiro; Eva Goncalvesova; Avishay Grupper; Righab Hamdan; Yoav Hammer; Loreena Hill; Osnat Itzhaki Ben Zadok; Miriam Abuhazira; Jacob Lavee; Wilfried Mullens; Sanemn Nalbantgil; Massimo F Piepoli; Piotr Ponikowski; Arsen Ristic; Arjang Ruhparwar; Aviv Shaul; Laurens F Tops; Steven Tsui; Stephan Winnik; Tiny Jaarsma; Finn Gustafsson; Tuvia Ben Gal
Journal:  ESC Heart Fail       Date:  2021-09-14

7.  Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices.

Authors:  Michael Yaoyao Yin; Jennifer Strege; Edward M Gilbert; Josef Stehlik; Stephen H McKellar; Ashley Elmer; Thomas Anderson; Mossab Aljuaid; Jose Nativi-Nicolau; Antigone G Koliopoulou; Erin Davis; James C Fang; Stavros G Drakos; Craig H Selzman; Omar Wever-Pinzon
Journal:  JACC Heart Fail       Date:  2020-04       Impact factor: 12.035

Review 8.  External cardiac compression during cardiopulmonary resuscitation of patients with left ventricular assist devices.

Authors:  Nigel T Mabvuure; Jeremy N Rodrigues
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-05-13

9.  Feasibility and safety of laparoscopic colorectal surgeries for patients with left ventricular assist device.

Authors:  Fawaz Abo-Alhassan; Bertrand Trilling; Pierre-Yves Sage; Edouard Girard; Jean-Luc Faucheron
Journal:  Int J Colorectal Dis       Date:  2019-09-13       Impact factor: 2.571

10.  Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.

Authors:  Travis D Richardson; Leslie Hale; Christopher Arteaga; Meng Xu; Mary Keebler; Kelly Schlendorf; Matthew Danter; Ashish Shah; JoAnn Lindenfeld; Christopher R Ellis
Journal:  J Am Heart Assoc       Date:  2018-02-23       Impact factor: 5.501

View more
  3 in total

1.  HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non-hospital settings in the community.

Authors:  Binyamin Ben Avraham; Marisa Generosa Crespo-Leiro; Gerasimos Filippatos; Israel Gotsman; Petar Seferovic; Tal Hasin; Luciano Potena; Davor Milicic; Andrew J S Coats; Giuseppe Rosano; Frank Ruschitzka; Marco Metra; Stefan Anker; Johann Altenberger; Stamatis Adamopoulos; Yaron D Barac; Ovidiu Chioncel; Nicolaas De Jonge; Jeremy Elliston; Maria Frigeiro; Eva Goncalvesova; Avishay Grupper; Righab Hamdan; Yoav Hammer; Loreena Hill; Osnat Itzhaki Ben Zadok; Miriam Abuhazira; Jacob Lavee; Wilfried Mullens; Sanemn Nalbantgil; Massimo F Piepoli; Piotr Ponikowski; Arsen Ristic; Arjang Ruhparwar; Aviv Shaul; Laurens F Tops; Steven Tsui; Stephan Winnik; Tiny Jaarsma; Finn Gustafsson; Tuvia Ben Gal
Journal:  ESC Heart Fail       Date:  2021-09-14

2.  The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection.

Authors:  Chung-Yi Cheng; Te-Chao Fang; Hung-Wei Liao; Tso-Hsiao Chen; Jer-Hwa Chang; Yen-Chung Lin; Chih-Chin Kao; Ming-Che Liu; Hui-Wen Chang; Ching-Sheng Hung; Jude Chu-Chun Wang; Shih-Hsin Hsiao; Yuh-Mou Sue
Journal:  Vaccines (Basel)       Date:  2022-02-21

3.  Corrigendum.

Authors: 
Journal:  ESC Heart Fail       Date:  2022-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.